PTC Therapeutics (PTCT)

PTC Therapeutics (PTCT) Stock Price & Analysis


PTCT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$23.57 - $59.84
Previous Close$24.82
Average Volume (3M)831.97K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$337.94M
Total Debt (Recent Filing)$702.68M
Price to Earnings (P/E)-2.9
Oct 26, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.42
Shares Outstanding75,344,951
10 Day Avg. Volume2,117,888
30 Day Avg. Volume831,971
Standard Deviation0.12
Financial Highlights & Ratios
Price to Book (P/B)-1.64
Price to Sales (P/S)10.71
Price to Cash Flow (P/CF)4.00
P/FCF Ratio4.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside60.62% Upside
Rating ConsensusHold
Number of Analyst Covering14



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was PTC Therapeutics’s price range in the past 12 months?
PTC Therapeutics lowest stock price was $23.57 and its highest was $59.84 in the past 12 months.
    What is PTC Therapeutics’s market cap?
    Currently, no data Available
    When is PTC Therapeutics’s upcoming earnings report date?
    PTC Therapeutics’s upcoming earnings report date is Oct 26, 2023 which is in 33 days.
      How were PTC Therapeutics’s earnings last quarter?
      PTC Therapeutics released its earnings results on Aug 03, 2023. The company reported -$2.66 earnings per share for the quarter, missing the consensus estimate of -$1.621 by -$1.039.
        Is PTC Therapeutics overvalued?
        According to Wall Street analysts PTC Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does PTC Therapeutics pay dividends?
          PTC Therapeutics does not currently pay dividends.
          What is PTC Therapeutics’s EPS estimate?
          PTC Therapeutics’s EPS estimate is -$1.17.
            How many shares outstanding does PTC Therapeutics have?
            PTC Therapeutics has 75,344,950 shares outstanding.
              What happened to PTC Therapeutics’s price movement after its last earnings report?
              PTC Therapeutics reported an EPS of -$2.66 in its last earnings report, missing expectations of -$1.621. Following the earnings report the stock price went down -3.993%.
                Which hedge fund is a major shareholder of PTC Therapeutics?
                Among the largest hedge funds holding PTC Therapeutics’s share is Blackstone Inc.. It holds PTC Therapeutics’s shares valued at 45M.


                  PTC Therapeutics Stock Smart Score

                  The PTC Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  PTC Therapeutics

                  PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.


                  Top 5 ETFs holding PTCT

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Schwab U.S. Broad Market ETF
                  Fidelity Nasdaq Composite Index ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold PTCT. The ETFs are listed according to market value of PTCT within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Sarepta Therapeutics
                  Crispr Therapeutics AG

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis